Search

everythinglearnresearchcommunity

for

Search:↓

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.